Pacira board rejects director Laura Brege's resignation after majority withhold vote

Pacira BioSciences, Inc.

Laura Brege received majority withhold votes at 2024 annual meeting; tendered resignation per company policy.
Independent directors unanimously rejected resignation after considering her qualifications, attendance, and prior support.
Brege stepped down from HLS Therapeutics board on Aug 7 to address overboarding; remains Pacira director until 2027.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.